RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
Overview[ - collapse ][ - ]
Purpose | This study is a phase 3b, multicentre, randomised, open label, parallel group study. A 4-week run-in period will be followed by a median of 6 years of treatment with study medication in addition to continuation of background glucose lowering therapy. Patients inadequately controlled on background metformin will be randomised to receive, in addition to metformin, either rosiglitazone or a sulfonylurea(glibenclamide, gliclazide or glimepiride) in a ratio of 1:1. Patients inadequately controlled on background SU will be randomised to receive, in addition to SU, either rosiglitazone or metformin in a ratio of 1:1. Equal numbers of patients receiving background metformin and SU at entry will be entered into the study. |
---|---|
Condition | Diabetes Mellitus, Type 2 |
Intervention | Drug: Rosiglitazone Drug: Sulfonylurea Drug: Metformin |
Phase | Phase 3 |
Sponsor | GlaxoSmithKline |
Responsible Party | GlaxoSmithKline |
ClinicalTrials.gov Identifier | NCT00379769 |
First Received | September 21, 2006 |
Last Updated | December 13, 2013 |
Last verified | December 2013 |
Tracking Information[ + expand ][ + ]
First Received Date | September 21, 2006 |
---|---|
Last Updated Date | December 13, 2013 |
Start Date | April 2001 |
Estimated Primary Completion Date | December 2008 |
Current Primary Outcome Measures |
|
Current Secondary Outcome Measures |
|
Descriptive Information[ + expand ][ + ]
Brief Title | RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes |
---|---|
Official Title | A Long Term, Open Label, Randomised Study in Patients With Type 2 Diabetes, Comparing the Combination of Rosiglitazone and Either Metformin or Sulfonylurea With Metformin Plus Sulfonylurea on Cardiovascular Endpoints and Glycaemia |
Brief Summary | This study is a phase 3b, multicentre, randomised, open label, parallel group study. A 4-week run-in period will be followed by a median of 6 years of treatment with study medication in addition to continuation of background glucose lowering therapy. Patients inadequately controlled on background metformin will be randomised to receive, in addition to metformin, either rosiglitazone or a sulfonylurea(glibenclamide, gliclazide or glimepiride) in a ratio of 1:1. Patients inadequately controlled on background SU will be randomised to receive, in addition to SU, either rosiglitazone or metformin in a ratio of 1:1. Equal numbers of patients receiving background metformin and SU at entry will be entered into the study. |
Detailed Description | A RECORD follow-up study is being performed to monitor the incidence of cancer and bone fractures in RECORD patients for a period of 4 years after the end of the main RECORD study (2008 - 2012). |
Study Type | Interventional |
Study Phase | Phase 3 |
Study Design | Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment |
Condition | Diabetes Mellitus, Type 2 |
Intervention | Drug: Rosiglitazone Rosiglitazone maximum 8 mg per day Drug: Sulfonylurea Sulfonylurea (SU) maximum permitted daily dose Drug: Metformin Metformin maximum permitted daily dose . |
Study Arm (s) |
|
Recruitment Information[ + expand ][ + ]
Recruitment Status | Completed |
---|---|
Estimated Enrollment | 4447 |
Estimated Completion Date | December 2008 |
Estimated Primary Completion Date | December 2008 |
Eligibility Criteria | Inclusion Criteria: - Patients with type II diabetes mellitus as defined by 1999 World Health Organisation criteria. - Glycated haemoglobin (HbA1c) >7.0 % to = 9.0 % at visit 1. - Use of an oral glucose lowering agent for a minimum of 6 months prior to screening and unchanged for 2 months prior to screening. - Body mass index >25.0 kg/m2. Exclusion Criteria: - Patients receiving any other glucose lowering therapy which is not metformin or a sulfonylurea. - Patients with systolic blood pressure >180 mmHg or diastolic blood pressure >105 mmHg. - Patients who have required the use of insulin for glycaemic control at any time in the past. - Hospitalisation for any major cardiovascular event in the last 3 months. |
Gender | Both |
Ages | 40 Years |
Accepts Healthy Volunteers | No |
Contacts | Not Provided |
Location Countries | Australia, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom |
Administrative Information[ + expand ][ + ]
NCT Number | NCT00379769 |
---|---|
Other Study ID Numbers | BRL-049653/231 |
Has Data Monitoring Committee | Yes |
Information Provided By | GlaxoSmithKline |
Study Sponsor | GlaxoSmithKline |
Collaborators | Not Provided |
Investigators | Study Director: GSK Clinical Trials GlaxoSmithKline |
Verification Date | December 2013 |
Locations[ + expand ][ + ]
GSK Investigational Site | Miranda, New South Wales, Australia, 2228 |
---|---|
GSK Investigational Site | Randwick, New South Wales, Australia, 2031 |
GSK Investigational Site | Wollongong, New South Wales, Australia, 2500 |
GSK Investigational Site | Carina Heights, Queensland, Australia, 4152 |
GSK Investigational Site | Kippa Ring, Queensland, Australia, 4021 |
GSK Investigational Site | Sherwood, Queensland, Australia, 4075 |
GSK Investigational Site | Keswick, South Australia, Australia, 5035 |
GSK Investigational Site | North Adelaide, South Australia, Australia, 5006 |
GSK Investigational Site | Port Lincoln, South Australia, Australia, 5606 |
GSK Investigational Site | Heidelberg, Victoria, Australia, 3084 |
GSK Investigational Site | Malvern, Victoria, Australia, 3144 |
GSK Investigational Site | Antwerpen, Belgium, 2000 |
GSK Investigational Site | Arlon, Belgium, 6700 |
GSK Investigational Site | Brussels, Belgium, 1090 |
GSK Investigational Site | Edegem, Belgium, 2650 |
GSK Investigational Site | Genk, Belgium, 3600 |
GSK Investigational Site | Gent, Belgium, 9000 |
GSK Investigational Site | Kortrijk, Belgium, 8500 |
GSK Investigational Site | Liege, Belgium, 4000 |
GSK Investigational Site | Moerkerke, Belgium, 8340 |
GSK Investigational Site | Oostham, Belgium, 3945 |
GSK Investigational Site | Roeselare, Belgium, 8800 |
GSK Investigational Site | Sint Gillis-Waas, Belgium, 9170 |
GSK Investigational Site | Vilvoorde, Belgium, 1800 |
GSK Investigational Site | Pleven, Bulgaria, 5800 |
GSK Investigational Site | Plovdiv, Bulgaria, 4002 |
GSK Investigational Site | Sofia, Bulgaria, 1606 |
GSK Investigational Site | Sofia, Bulgaria, 1301 |
GSK Investigational Site | Sofia, Bulgaria, 1431/1000 |
GSK Investigational Site | Sofia, Bulgaria, 1303 |
GSK Investigational Site | Sofia, Bulgaria, 1233 |
GSK Investigational Site | Varna, Bulgaria, 9010 |
GSK Investigational Site | Krapinske Toplice, Croatia, 49217 |
GSK Investigational Site | Rijeka, Croatia, 51000 |
GSK Investigational Site | Slavonski Brod, Croatia, 35000 |
GSK Investigational Site | Varaždin, Croatia, 42000 |
GSK Investigational Site | Zagreb, Croatia, 10000 |
GSK Investigational Site | Brno, Czech Republic, 625 00 |
GSK Investigational Site | Ceske Budejovice, Czech Republic, 370 87 |
GSK Investigational Site | Holice V Cechach, Czech Republic, 534 01 |
GSK Investigational Site | Hradec Kralove, Czech Republic, 500 05 |
GSK Investigational Site | Jindrichuv Hradec, Czech Republic, 377 38 |
GSK Investigational Site | Ostrava Poruba, Czech Republic, 708 52 |
GSK Investigational Site | Pisek, Czech Republic, 397 01 |
GSK Investigational Site | Praha 2, Czech Republic, 128 42 |
GSK Investigational Site | Praha 4, Czech Republic, 140 21 |
GSK Investigational Site | Rakovnik, Czech Republic, 269 01 |
GSK Investigational Site | Tabor, Czech Republic, 390 00 |
GSK Investigational Site | Trutnov, Czech Republic, 541 21 |
GSK Investigational Site | Aalborg, Denmark, DK-9100 |
GSK Investigational Site | Aarhus, Denmark |
GSK Investigational Site | Copenhagen, Denmark, 2300 |
GSK Investigational Site | Glostrup, Denmark |
GSK Investigational Site | Hilleroed, Denmark, 3400 |
GSK Investigational Site | Koge, Denmark, 4600 |
GSK Investigational Site | Kolding, Denmark, DK-6000 |
GSK Investigational Site | København NV, Denmark |
GSK Investigational Site | Naestved, Denmark, 4700 |
GSK Investigational Site | Odense C, Denmark, DK-5000 |
GSK Investigational Site | Silkeborg, Denmark, 8600 |
GSK Investigational Site | Slagelse, Denmark, 4200 |
GSK Investigational Site | Paide, Estonia, 72714 |
GSK Investigational Site | Parnu, Estonia, 80018 |
GSK Investigational Site | Rakvere, Estonia, 44316 |
GSK Investigational Site | Saku, Estonia, 75501 |
GSK Investigational Site | Tallinn, Estonia, 13415 |
GSK Investigational Site | Tallinn, Estonia, 11911 |
GSK Investigational Site | Tallinn, Estonia, 10138 |
GSK Investigational Site | Tallinn, Estonia, 1162 |
GSK Investigational Site | Tartu, Estonia |
GSK Investigational Site | Viljandi, Estonia, 71024 |
GSK Investigational Site | Espoo, Finland, 02710 |
GSK Investigational Site | Espoo, Finland, 02600 |
GSK Investigational Site | Hanko, Finland, 10900 |
GSK Investigational Site | Helsinki, Finland, 00930 |
GSK Investigational Site | Helsinki, Finland, 00810 |
GSK Investigational Site | Helsinki, Finland, 00150 |
GSK Investigational Site | Hyvinkaa, Finland, 05800 |
GSK Investigational Site | Jyväskylä, Finland, 40100 |
GSK Investigational Site | Kerava, Finland, 04200 |
GSK Investigational Site | Kuopio, Finland, 70210 |
GSK Investigational Site | Lahti, Finland, 15850 |
GSK Investigational Site | Lappeenranta, Finland, 53100 |
GSK Investigational Site | Oulun kaupunki, Finland, 90015 |
GSK Investigational Site | Riihimäki, Finland, 11130 |
GSK Investigational Site | Rovaniemi, Finland |
GSK Investigational Site | Seinajoki, Finland, 60220 |
GSK Investigational Site | Tampere, Finland, 33100 |
GSK Investigational Site | Turku, Finland, 20100 |
GSK Investigational Site | Turku, Finland, 20700 |
GSK Investigational Site | Bully Les Mines, Nord-Pas-de-Calais, France, 62160 |
GSK Investigational Site | Amilly, France, 28300 |
GSK Investigational Site | Arras, France, 62000 |
GSK Investigational Site | Aspach le Bas 68700, France, 68700 |
GSK Investigational Site | Aubagne, France, 13400 |
GSK Investigational Site | Auchy les Hesdin, France, 62770 |
GSK Investigational Site | Azille, France, 11700 |
GSK Investigational Site | Beaumont Le Roger, France, 21170 |
GSK Investigational Site | Beaumont sur Leze, France, 31870 |
GSK Investigational Site | Belfort, France, 90000 |
GSK Investigational Site | Belpech, France, 11420 |
GSK Investigational Site | Blotzheim, France |
GSK Investigational Site | Bondy, France, 93143 |
GSK Investigational Site | BP 1542 Dijon, France, 21034 |
GSK Investigational Site | Broglie, France, 27270 |
GSK Investigational Site | Calmont, France, 31560 |
GSK Investigational Site | Carbonne, France, 31390 |
GSK Investigational Site | Carcassonne, France, 11000 |
GSK Investigational Site | Carcassonne, France |
GSK Investigational Site | Carcassonne 11000, France, 11000 |
GSK Investigational Site | Cassis, France, 13260 |
GSK Investigational Site | Castelnaudary, France, 11400 |
GSK Investigational Site | Catelnaudary, France, 11400 |
GSK Investigational Site | Cernay, France, 68700 |
GSK Investigational Site | Champhol, France, 28300 |
GSK Investigational Site | Chartres, France, 28000 |
GSK Investigational Site | Colmar, France, 68000 |
GSK Investigational Site | Corbeil Essonne, France, 91014 |
GSK Investigational Site | Coursan, France, 11110 |
GSK Investigational Site | Cuincy, France, 59553 |
GSK Investigational Site | Danjoutin, France, 90400 |
GSK Investigational Site | Dessenheim, France, 68600 |
GSK Investigational Site | Dieppe, France, 76200 |
GSK Investigational Site | Dunkerque, France, 59385 |
GSK Investigational Site | Epernon, France, 28230 |
GSK Investigational Site | Gemenos, France, 13420 |
GSK Investigational Site | Hanches, France, 28130 |
GSK Investigational Site | Hautot sur Mer, France, 76550 |
GSK Investigational Site | Husseren Wesserling, France, 68470 |
GSK Investigational Site | Kembs, France, 68680 |
GSK Investigational Site | La Barre En Ouche, France, 27330 |
GSK Investigational Site | La Verdière, France, 83560 |
GSK Investigational Site | Labarth-Sur-Leze, France, 31860 |
GSK Investigational Site | Labarthe-Sur-Leze, France, 31860 |
GSK Investigational Site | Le Grau Du Roi, France, 30240 |
GSK Investigational Site | Le Lherm 31600, France, 31600 |
GSK Investigational Site | Le Perray En Yvelines, France, 78610 |
GSK Investigational Site | Lezignan-Corbières, France, 11200 |
GSK Investigational Site | Maintenon, France, 28130 |
GSK Investigational Site | Marseille, France, 13003 |
GSK Investigational Site | Marseille, France, 13008 |
GSK Investigational Site | Marseille, France, 13016 |
GSK Investigational Site | Marseille, France, 13014 |
GSK Investigational Site | Marseille, France, 13011 |
GSK Investigational Site | Marseille, France, 13001 |
GSK Investigational Site | Marseille, France, 13013 |
GSK Investigational Site | Masevaux, France, 68290 |
GSK Investigational Site | Maubeuge, France, 59600 |
GSK Investigational Site | Monfort sur Risle, France, 27290 |
GSK Investigational Site | Mulhouse, France, 68100 |
GSK Investigational Site | Muret, France, 31600 |
GSK Investigational Site | Nassandres, France, 27550 |
GSK Investigational Site | Nevers cedex, France, 58033 |
GSK Investigational Site | Nogent le Phaye, France, 28630 |
GSK Investigational Site | Orbec, France, 14290 |
GSK Investigational Site | Paris, France, 75730 |
GSK Investigational Site | Pierre Benite Cedex, France, 69495 |
GSK Investigational Site | Pierres, France, 28130 |
GSK Investigational Site | Pinsaguel, France, 31120 |
GSK Investigational Site | Roux Mesnil Bouteille, France, 76370 |
GSK Investigational Site | Rugles, France, 27250 |
GSK Investigational Site | Saint Leger sur Yvelines, France, 78610 |
GSK Investigational Site | Saint-Eulalie Badens, France, 11800 |
GSK Investigational Site | Seysses, France, 31600 |
GSK Investigational Site | Thann, France, 68800 |
GSK Investigational Site | Thiberville, France, 27230 |
GSK Investigational Site | Toulouse, France, 31400 |
GSK Investigational Site | Toulouse, France, 31000 |
GSK Investigational Site | Toulouse, France, 31500 |
GSK Investigational Site | Trebbes, France, 01800 |
GSK Investigational Site | Trebes, France, 11800 |
GSK Investigational Site | Valenciennes, France, 59322 |
GSK Investigational Site | Vogelsheim, France, 68600 |
GSK Investigational Site | Voves, France, 28150 |
GSK Investigational Site | Wittenheim, France, 68270 |
GSK Investigational Site | Heidelberg, Baden-Wuerttemberg, Germany, 69120 |
GSK Investigational Site | Sinsheim, Baden-Wuerttemberg, Germany, 74889 |
GSK Investigational Site | Stuttgart, Baden-Wuerttemberg, Germany, 70197 |
GSK Investigational Site | Kronach, Bayern, Germany, 96317 |
GSK Investigational Site | Wuerzburg, Bayern, Germany, 97070 |
GSK Investigational Site | Kronberg, Hessen, Germany, 61476 |
GSK Investigational Site | Ober-Moerlen, Hessen, Germany, 61239 |
GSK Investigational Site | Offenbach, Hessen, Germany, 63071 |
GSK Investigational Site | Wetzlar, Hessen, Germany, 35578 |
GSK Investigational Site | Bad Lauterberg, Niedersachsen, Germany, 37431 |
GSK Investigational Site | Beckum, Nordrhein-Westfalen, Germany, 59269 |
GSK Investigational Site | Menden, Nordrhein-Westfalen, Germany, 58706 |
GSK Investigational Site | Gau-Algesheim, Rheinland-Pfalz, Germany, 55435 |
GSK Investigational Site | Kallstadt, Rheinland-Pfalz, Germany, 67169 |
GSK Investigational Site | Lambrecht, Rheinland-Pfalz, Germany, 67466 |
GSK Investigational Site | Rhaunen, Rheinland-Pfalz, Germany, 55624 |
GSK Investigational Site | Speyer, Rheinland-Pfalz, Germany, 67346 |
GSK Investigational Site | Friedrichsthal, Saarland, Germany, 66299 |
GSK Investigational Site | Burgstaedt, Sachsen, Germany, 09217 |
GSK Investigational Site | Chemnitz, Sachsen, Germany, 09130 |
GSK Investigational Site | Dresden, Sachsen, Germany, 01307 |
GSK Investigational Site | Leipzig, Sachsen, Germany, 04103 |
GSK Investigational Site | Suhl, Thueringen, Germany, 98529 |
GSK Investigational Site | Hamburg, Germany, 20249 |
GSK Investigational Site | Athens, Greece, 18537 |
GSK Investigational Site | Athens, Greece, 11521 |
GSK Investigational Site | Athens, Greece, 115 27 |
GSK Investigational Site | Athens, Greece, 11527 |
GSK Investigational Site | Haidari, Athens, Greece, 12462 |
GSK Investigational Site | Ioannina, Greece, 45001 |
GSK Investigational Site | Maroussi, Greece, 15123 |
GSK Investigational Site | Patra, Greece, 26335 |
GSK Investigational Site | Patra, Greece, 26500 |
GSK Investigational Site | Piraeus-Athens, Greece, 18536 |
GSK Investigational Site | Piraeus-Athens, Greece, 18454 |
GSK Investigational Site | Thessaloniki, Greece, 564 29 |
GSK Investigational Site | Thessalonikis, Greece, 57010 |
GSK Investigational Site | Budapest, Hungary, 1125 |
GSK Investigational Site | Budapest, Hungary, 1145 |
GSK Investigational Site | Budapest, Hungary, 1096 |
GSK Investigational Site | Budapest, Hungary, 1097 |
GSK Investigational Site | Budapest, Hungary, 1115 |
GSK Investigational Site | Budapest, Hungary, 1062 |
GSK Investigational Site | Budapest, Hungary, 1083 |
GSK Investigational Site | Debrecen, Hungary, 4043 |
GSK Investigational Site | Eger, Hungary |
GSK Investigational Site | Gyor, Hungary, 9024 |
GSK Investigational Site | Gyula, Hungary, 5701 |
GSK Investigational Site | Kurtag99, Hungary |
GSK Investigational Site | Nyiregyháza, Hungary, 4400 |
GSK Investigational Site | Patkaj98, Hungary |
GSK Investigational Site | Siofok, Hungary, 8601 |
GSK Investigational Site | Szentes, Hungary, 6600 |
GSK Investigational Site | Szombathely, Hungary, 9700 |
GSK Investigational Site | Veszprem, Hungary, 8200 |
GSK Investigational Site | Zalaegerszeg, Hungary, 8900 |
GSK Investigational Site | Reggio Calabria, Calabria, Italy, 89100 |
GSK Investigational Site | Napoli, Campania, Italy, 80136 |
GSK Investigational Site | Nocera Inferiore (SA), Campania, Italy, 84014 |
GSK Investigational Site | Salerno, Campania, Italy, 84100 |
GSK Investigational Site | Bologna, Emilia-Romagna, Italy, 40138 |
GSK Investigational Site | Rimini, Emilia-Romagna, Italy, 47900 |
GSK Investigational Site | Roma, Lazio, Italy, 00168 |
GSK Investigational Site | Roma, Lazio, Italy, 00155 |
GSK Investigational Site | Genova, Liguria, Italy, 16132 |
GSK Investigational Site | Brescia, Lombardia, Italy, 25123 |
GSK Investigational Site | Milano, Lombardia, Italy, 20162 |
GSK Investigational Site | San Donato (MI), Lombardia, Italy, 20097 |
GSK Investigational Site | Treviglio (BG), Lombardia, Italy, 13115 |
GSK Investigational Site | Campobasso, Molise, Italy, 86100 |
GSK Investigational Site | Torino, Piemonte, Italy, 10122 |
GSK Investigational Site | Cagliari, Sardegna, Italy, 09127 |
GSK Investigational Site | Sassari, Sardegna, Italy, 07100 |
GSK Investigational Site | Palermo, Sicilia, Italy, 90127 |
GSK Investigational Site | Pisa, Toscana, Italy, 56126 |
GSK Investigational Site | Bari, Italy, 70124 |
GSK Investigational Site | Parma, Italy, 43100 |
GSK Investigational Site | Roma, Italy, 00168 |
GSK Investigational Site | Jekabpils, Latvia, LV 5201 |
GSK Investigational Site | Lagzdi60, Latvia |
GSK Investigational Site | Limbazi, Latvia, LV 4001 |
GSK Investigational Site | Ogre, Latvia, LV 5001 |
GSK Investigational Site | Riga, Latvia, LV 1057 |
GSK Investigational Site | Riga, Latvia, LV 1011 |
GSK Investigational Site | Riga, Latvia, 1006 |
GSK Investigational Site | Riga, Latvia, LV1002 |
GSK Investigational Site | Sturii59, Latvia |
GSK Investigational Site | Tukums, Latvia, LV 3100 |
GSK Investigational Site | Kaunas, Lithuania, LT-49476 |
GSK Investigational Site | Kaunas, Lithuania, LT-47144 |
GSK Investigational Site | Kaunas, Lithuania, LT-51270 |
GSK Investigational Site | Kaunas, Lithuania, LT-50009 |
GSK Investigational Site | Klaipeda, Lithuania, 92304 |
GSK Investigational Site | Vilnius, Lithuania, LT-04318 |
GSK Investigational Site | Vilnius, Lithuania, LT-10103 |
GSK Investigational Site | Vilnius, Lithuania, LT 08661 |
GSK Investigational Site | Geleen, Netherlands, 6160 BB |
GSK Investigational Site | Groningen, Netherlands, 9711 SG |
GSK Investigational Site | Hengelo, Netherlands, 7555 DL |
GSK Investigational Site | Hoogvliet, Netherlands, 3192 JN |
GSK Investigational Site | Kerkrade, Netherlands, 6461 XP |
GSK Investigational Site | Landgraaf, Netherlands, 6373 JS |
GSK Investigational Site | Musselkanaal, Netherlands, 9581 AD |
GSK Investigational Site | Nijmegen, Netherlands, 6525 EC |
GSK Investigational Site | Oude Pekela, Netherlands, 9665 AR |
GSK Investigational Site | Ridderkerk, Netherlands, 2985 BV |
GSK Investigational Site | Rijswijk, Netherlands, 2281 AK |
GSK Investigational Site | Roosendaal, Netherlands, 4701 LJ |
GSK Investigational Site | Rotterdam, Netherlands, 3082 KC |
GSK Investigational Site | Rotterdam, Netherlands, 3021 HC |
GSK Investigational Site | St. Willebrord, Netherlands, 4711 EG |
GSK Investigational Site | Zoetermeer, Netherlands, 2724 EK |
GSK Investigational Site | Zwijndrecht, Netherlands, 3334 XA |
GSK Investigational Site | Zwijndrecht, Netherlands, 3331 AE |
GSK Investigational Site | Christchurch, New Zealand, 8011 |
GSK Investigational Site | Dunedin, New Zealand, 9016 |
GSK Investigational Site | Hastings, New Zealand, Private Bag 9014 |
GSK Investigational Site | Otahuhu, Auckland, New Zealand, 2025 |
GSK Investigational Site | Palmerston North, New Zealand, 4410 |
GSK Investigational Site | Takapuna, Auckland, New Zealand, 0620 |
GSK Investigational Site | Tauranga, New Zealand, 3112 |
GSK Investigational Site | Wellington, New Zealand, 6002 |
GSK Investigational Site | Bialystok, Poland, 15-276 |
GSK Investigational Site | Bydgoszcz, Poland, 85 822 |
GSK Investigational Site | Gdansk, Poland, 80 211 |
GSK Investigational Site | Grudziadz, Poland, 86-300 |
GSK Investigational Site | Krakow, Poland, 31 501 |
GSK Investigational Site | Krakow, Poland, 31 261 |
GSK Investigational Site | Lodz, Poland, 90 030 |
GSK Investigational Site | Lublin, Poland, 20-718 |
GSK Investigational Site | Lublin, Poland, 02 081 |
GSK Investigational Site | Olsztyn, Poland, 10 461 |
GSK Investigational Site | Poznan, Poland, 61 696 |
GSK Investigational Site | Poznan, Poland, 60-834 |
GSK Investigational Site | Warszawa, Poland, 02 507 |
GSK Investigational Site | Warszawa, Poland, 01-337 |
GSK Investigational Site | Warszawa, Poland, 01 887 |
GSK Investigational Site | Warszawa, Poland, 02-042 |
GSK Investigational Site | Wroclaw, Poland, 50-127 |
GSK Investigational Site | Bucharest, Romania, 020475 |
GSK Investigational Site | Bucuresti, Romania, 011234 |
GSK Investigational Site | Bucuresti, Romania, 022448 |
GSK Investigational Site | Cluj-Napoca, Romania, 400006 |
GSK Investigational Site | Craiova, Romania, 2000642 |
GSK Investigational Site | Iasi, Romania, 700111 |
GSK Investigational Site | Timisoara, Romania, 293406 |
GSK Investigational Site | Moscow, Russian Federation, 129110 |
GSK Investigational Site | Moscow, Russian Federation, 115 280 |
GSK Investigational Site | Moscow, Russian Federation, 117049 |
GSK Investigational Site | Moscow, Russian Federation, 125367 |
GSK Investigational Site | St Petersburg, Russian Federation, 195257 |
GSK Investigational Site | St-Petersburg, Russian Federation, 194291 |
GSK Investigational Site | Banska Bystrica, Slovakia, 975 17 |
GSK Investigational Site | Bratislava, Slovakia, 82108 |
GSK Investigational Site | Bratislava, Slovakia, 811 08 |
GSK Investigational Site | Bratislava, Slovakia, 813 69 |
GSK Investigational Site | Bratislava, Slovakia, 82102 |
GSK Investigational Site | Kosice, Slovakia, 040 11 |
GSK Investigational Site | Kosice, Slovakia, 041 90 |
GSK Investigational Site | Kysucke Nove Mesto, Slovakia, 024 01 |
GSK Investigational Site | Lubochna, Slovakia, 034 91 |
GSK Investigational Site | Lucenec, Slovakia, 984 01 |
GSK Investigational Site | Presov, Slovakia, 08001 |
GSK Investigational Site | Prievidza, Slovakia, 97201 |
GSK Investigational Site | Sahy, Slovakia, 936 01 |
GSK Investigational Site | Samorin, Slovakia, 931 01 |
GSK Investigational Site | Trencin, Slovakia, 911 01 |
GSK Investigational Site | Zilina, Slovakia, 010 01 |
GSK Investigational Site | Badalona, Spain, 08911 |
GSK Investigational Site | Barcelona, Spain, 08036 |
GSK Investigational Site | Barcelona, Spain, 08025 |
GSK Investigational Site | Benidorm, Spain, 03500 |
GSK Investigational Site | Bilbao, Spain, 48903 |
GSK Investigational Site | Caceres, Spain, 10003 |
GSK Investigational Site | Cadiz, Spain, 11009 |
GSK Investigational Site | Granada, Spain, 18012 |
GSK Investigational Site | Madrid, Spain, 28034 |
GSK Investigational Site | Madrid, Spain, 28040 |
GSK Investigational Site | Palma de Mallorca, Spain, 7014 |
GSK Investigational Site | Reus, Spain, 43201 |
GSK Investigational Site | Santander, Spain, 38008 |
GSK Investigational Site | Vazquc56, Spain |
GSK Investigational Site | Vizcaya, Spain, 48910 |
GSK Investigational Site | Vizcaya, Spain, 48920 |
GSK Investigational Site | Eksjö, Sweden, SE-575 81 |
GSK Investigational Site | Göteborg, Sweden, SE-417 17 |
GSK Investigational Site | Göteborg, Sweden, SE-416 65 |
GSK Investigational Site | Göteborg, Sweden, SE-413 45 |
GSK Investigational Site | Helsingborg, Sweden, SE-254 37 |
GSK Investigational Site | Kristianstad, Sweden, SE-291 85 |
GSK Investigational Site | Kungälv, Sweden, SE-442 83 |
GSK Investigational Site | Köping, Sweden, SE-73181 |
GSK Investigational Site | Linköpiing, Sweden, SE-582 25 |
GSK Investigational Site | Linköping, Sweden, SE-582 46 |
GSK Investigational Site | Lund, Sweden, SE-221 85 |
GSK Investigational Site | Mora, Sweden, SE-792 85 |
GSK Investigational Site | Nacka, Sweden, SE-131 83 |
GSK Investigational Site | Norrköping, Sweden, SE-602 20 |
GSK Investigational Site | Oskarshamn, Sweden, SE-572 28 |
GSK Investigational Site | Skene, Sweden, SE-511 62 |
GSK Investigational Site | Stockholm, Sweden, SE-182 88 |
GSK Investigational Site | Uddevalla, Sweden, SE-451 40 |
GSK Investigational Site | Umeå, Sweden, SE-901 85 |
GSK Investigational Site | Uppsala, Sweden, SE-751 25 |
GSK Investigational Site | Vadstena, Sweden, SE-592 32 |
GSK Investigational Site | Dnepropetrovsk, Ukraine, 49044 |
GSK Investigational Site | Kharkiv, Ukraine, 61002 |
GSK Investigational Site | Kiev, Ukraine, 02175 |
GSK Investigational Site | Kiev, Ukraine, 04114 |
GSK Investigational Site | Kyiv, Ukraine, 01004 |
GSK Investigational Site | Lvov, Ukraine, 79010 |
GSK Investigational Site | Vinnitsa, Ukraine, 21010 |
GSK Investigational Site | Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ |
GSK Investigational Site | Fowley, Cornwall, United Kingdom, PL23 1DT |
GSK Investigational Site | Chesterfield, Derbyshire, United Kingdom, S44 6DE |
GSK Investigational Site | Chesterfield, Derbyshire, United Kingdom, S40 4TF |
GSK Investigational Site | Airdrie, Lanarkshire, United Kingdom, ML6 0JS |
GSK Investigational Site | Glasgow, Lanarkshire, United Kingdom |
GSK Investigational Site | Glasgow, Lanarkshire, United Kingdom, G51 4TF |
GSK Investigational Site | Hamilton, Lanarkshire, United Kingdom, ML3 0DR |
GSK Investigational Site | Motherwell, Lanarkshire, United Kingdom, ML1 3JX |
GSK Investigational Site | Leicester, Leicestershire, United Kingdom, LE1 5WW |
GSK Investigational Site | Northampton, Northamptonshire, United Kingdom, NN5 7AQ |
GSK Investigational Site | Northampton, Northamptonshire, United Kingdom, NN1 5BD |
GSK Investigational Site | Linwood, Renfrewshire, United Kingdom |
GSK Investigational Site | Paisley, Renfrewshire, United Kingdom, PA1 1UB |
GSK Investigational Site | Frome, Somerset, United Kingdom, BA11 1EZ |
GSK Investigational Site | Glastonbury, Somerset, United Kingdom, BA6 9LP |
GSK Investigational Site | Rugby, Warwickshire, United Kingdom, CV21 3SP |
GSK Investigational Site | Rugby, Warwickshire, United Kingdom, CV22 5PX |
GSK Investigational Site | Corsham, Wiltshire, United Kingdom, SN13 9DL |
GSK Investigational Site | Trowbridge, Wiltshire, United Kingdom, BA14 8QA |
GSK Investigational Site | Trowbridge, Wiltshire, United Kingdom, BA14 9AR |
GSK Investigational Site | Westbury, Wiltshire, United Kingdom, BA13 3JD |
GSK Investigational Site | Airdrie, United Kingdom, ML6 0JH |
GSK Investigational Site | Airdrie, United Kingdom, ML6 0JU |
GSK Investigational Site | Ashford, United Kingdom, TW15 2TU |
GSK Investigational Site | Bath, United Kingdom, BA2 3HT |
GSK Investigational Site | Chesterfield, United Kingdom, S40 1LE |
GSK Investigational Site | Chippenham, United Kingdom, SN15 2SB |
GSK Investigational Site | Coatbridge, United Kingdom, ML5 3AP |
GSK Investigational Site | Colney, United Kingdom, NR4 7UY |
GSK Investigational Site | Cumbernauld, United Kingdom, G67 3BE |
GSK Investigational Site | Dronfield, United Kingdom, S18 1RU |
GSK Investigational Site | Dumbarton, United Kingdom, G82 1PW |
GSK Investigational Site | East Kilbride, United Kingdom, G75 8RG |
GSK Investigational Site | Falmouth, United Kingdom, TR11 2LH |
GSK Investigational Site | Garston, Watford, United Kingdom, WD2 6EB |
GSK Investigational Site | Gateshead, United Kingdom, NE9 6SX |
GSK Investigational Site | Glasgow, United Kingdom |
GSK Investigational Site | Glasgow, United Kingdom, G5 OPQ |
GSK Investigational Site | Hamilton, United Kingdom, ML3 8AA |
GSK Investigational Site | Harrow, United Kingdom, HA3 7LT |
GSK Investigational Site | Kirkintilloch, United Kingdom, G66 1JB |
GSK Investigational Site | Leigh on Sea, United Kingdom, SS9 2SQ |
GSK Investigational Site | Motherwell, United Kingdom, ML1 2PS |
GSK Investigational Site | Newcastle upon Tyne, United Kingdom, NE1 4LP |
GSK Investigational Site | Newport, United Kingdom, PO30 5TG |
GSK Investigational Site | Nottingham, United Kingdom, NG5 1PB |
GSK Investigational Site | Old Whittington, Chesterfield, United Kingdom, S41 9JZ |
GSK Investigational Site | Paisley, United Kingdom, PA3 2DY |
GSK Investigational Site | Penzance, United Kingdom, TR18 4JH |
GSK Investigational Site | Rubery, Birmingham, United Kingdom, B45 9JT |
GSK Investigational Site | Sheffield, United Kingdom, S5 7TW |
GSK Investigational Site | Sheffield, United Kingdom, S5 7QB |
GSK Investigational Site | Thornhill, United Kingdom, DG3 5AA |
GSK Investigational Site | Thornhill, Cardiff, United Kingdom, CF14 9BB |
GSK Investigational Site | Uddingston, United Kingdom, G71 5SU |
GSK Investigational Site | Weston Super Mare, United Kingdom, BS23 4BP |
GSK Investigational Site | Wishaw, United Kingdom, ML2 7BQ |
GSK Investigational Site | Woking, United Kingdom, GU21 1TD |
GSK Investigational Site | Worle, Weston-Super-Mare, United Kingdom, BS22 6AJ |